Möchten Sie immer auf dem neuesten Stand bleiben?

MONTRÉAL, 07 nov. 2025 (GLOBE NEWSWIRE) -- Les Industries Dorel Inc. (TSX : DII.B, DII.A) TÉLÉCONFÉRENCE:OUVERTE AUX :Analystes, investisseurs et autres personnes intéresséesDATE :Le lundi 10...

MONTREAL, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Dorel Industries, Inc.  (TSX: DII.B, DII.A) CONFERENCE CALL:OPEN TO:Analysts, investors and all interested partiesDATE:Monday, November 10,...

PONTE VEDRA, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. (“Treace” or the “Company”) (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the...

AI-based digital pathology analysis provides high-resolution quantification of hepatic fibrosis and objective measurement of fibrosis improvement Pemvidutide demonstrated significant reductions in...

HAMPTON, N.J., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Celldex (NASDAQ:CLDX) announced today that management will participate in fireside chats at the following upcoming investor conferences: ...

– Phase 1b data demonstrating favorable safety and tolerability profile and potent reductions in viral nucleic acids highlighted in late-breaking poster presentation – SOUTH SAN FRANCISCO, Calif.,...

BOSTON, Nov. 07, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it will participate in...

WEST PALM BEACH, Fla., Nov. 07, 2025 (GLOBE NEWSWIRE) -- Dycom Industries, Inc. (NYSE: DY) will host a conference call to discuss fiscal 2026 third quarter results on Wednesday, November 19, 2025,...

RONAN, Mont., Nov. 07, 2025 (GLOBE NEWSWIRE) -- AirJoule Technologies Corporation (NASDAQ: AIRJ) (“AirJoule Technologies” or the “Company”), a leading platform technology that unleashes the power of...

Phase 2 M-ACCEL trial in MASH met primary endpoint, with statistically significant reductions in liver fat observed in all HU6 treatment groups